Last reviewed · How we verify
QR-010
At a glance
| Generic name | QR-010 |
|---|---|
| Sponsor | ProQR Therapeutics |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation (PHASE1)
- Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |